Drugs List

Drugs A-Z List - R
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
R-Gene 10 arginine hydrochloride) Injection, USP - FDA

Description : Each 100 mL of R-Gene® 10 (Arginine Hydrochloride Injection, USP) for intravenous use c...

  • Indications
  • R-Gene® 10 (arginine hydrochloride injection) is indicated as an intravenous stimulant to the pituitary for the release of human growth hormone in patients where the m
  •   Read More
R-Gene 10 (arginine hydrochloride) Injection, USP - FDA

Description : Each 100 mL of R-Gene® 10 (Arginine Hydrochloride Injection, USP) for intravenous use c...

  • Indications
  • R-Gene® 10 (arginine hydrochloride injection) is indicated as an intravenous stimulant to the pituitary for the release of human growth hormone in patients where the m
  •   Read More
RabAvert rabies vaccine (purified chick embryo cell) (Pronu - FDA

Description : RabAvert, Rabies Vaccine, produced by Novartis Vaccines and Diagnostics GmbH is a sterile ...

  • Indications
  • RabAvert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. Usually, a
  •   Read More
RabAvert rabies vaccine (purified chick embryo cell) (Pronu - Multum

Description : RabAvert, Rabies Vaccine, produced by Novartis Vaccines and Diagnostics GmbH is a sterile ...

  • Indications
  • RabAvert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. Usually, a
  •   Read More
RabAvert rabies vaccine (purified chick embryo cell) (Pronu - FDA

Description : RabAvert, Rabies Vaccine, produced by Novartis Vaccines and Diagnostics GmbH is a sterile ...

  • Indications
  • RabAvert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. Usually, a
  •   Read More
RabAvert rabies vaccine (purified chick embryo cell) (Pronu - Multum

Description : RabAvert, Rabies Vaccine, produced by Novartis Vaccines and Diagnostics GmbH is a sterile ...

  • Indications
  • RabAvert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. Usually, a
  •   Read More
Radiesse (calcium hydroxylapatite particle in an aqueous ge - FDA

Description : RADIESSE® injectable implant is a sterile, non-pyrogenic, semi-solid, cohesive implant,...

  • Indications
  • RADIESSE injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is
  •   Read More
Radiesse (calcium hydroxylapatite particle in an aqueous ge - FDA

Description : RADIESSE® injectable implant is a sterile, non-pyrogenic, semi-solid, cohesive implant,...

  • Indications
  • RADIESSE injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is
  •   Read More
Radiogardase Prussian blue (Pronunciation: PRUSH an BLOO) - Multum

Description : Prussian blue insoluble capsules contain insoluble ferric hexacyanoferrate(II), with an empir...

  • Indications
  • Prussian blue insoluble is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive tha
  •   Read More
Radiogardase Prussian blue (Pronunciation: PRUSH an BLOO) - FDA

Description : Prussian blue insoluble capsules contain insoluble ferric hexacyanoferrate(II), with an empir...

  • Indications
  • Prussian blue insoluble is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive
  •   Read More
Radiogardase Prussian blue (Pronunciation: PRUSH an BLOO) - Multum

Description : Prussian blue insoluble capsules contain insoluble ferric hexacyanoferrate(II), with an empir...

  • Indications
  • Prussian blue insoluble is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive
  •   Read More
Ragwitek (Short Ragweed Pollen Allergen Extract) Tablets - FDA

Description : RAGWITEK tablets contain pollen allergen extract from Short Ragweed (Ambrosia artemisiifoli...

  • Indications
  • RAGWITEK™ is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, co
  •   Read More
Ragwitek RAGWITEK™ (Short Ragweed Pollen Allergen Extrac - FDA

Description : RAGWITEK tablets contain pollen allergen extract from Short Ragweed (Ambrosia artemisiifolia). ...

  • Indications
  • RAGWITEK™ is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with
  •   Read More
Ranexa ranolazine (Pronunciation: ra NOE la zeen) - FDA

Description : RANEXA (ranolazine) is available as a film-coated, non-scored, extended-release tablet for ...

  • Indications
  • RANEXA® is indicated for the treatment of chronic angina. RANEXA may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowe
  •   Read More
Ranexa ranolazine (Pronunciation: ra NOE la zeen) - Multum

Description : RANEXA (ranolazine) is available as a film-coated, non-scored, extended-release tablet for ...

  • Indications
  • RANEXA® is indicated for the treatment of chronic angina. RANEXA may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowe
  •   Read More
Ranexa ranolazine (Pronunciation: ra NOE la zeen) - FDA

Description : RANEXA (ranolazine) is available as a film-coated, non-scored, extended-release tablet for ...

  • Indications
  • RANEXA® is indicated for the treatment of chronic angina. RANEXA may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowe
  •   Read More
Ranexa ranolazine (Pronunciation: ra NOE la zeen) - Multum

Description : RANEXA (ranolazine) is available as a film-coated, non-scored, extended-release tablet for ...

  • Indications
  • RANEXA® is indicated for the treatment of chronic angina. RANEXA may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowe
  •   Read More
Rapaflo silodosin (Pronunciation: SIL oh DOE sin) - FDA

Description : RAPAFLO is the brand name for silodosin, a selective antagonist of alpha-1 adrenoreceptors...

  • Indications
  • RAPAFLO, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studi
  •   Read More
Rapaflo silodosin (Pronunciation: SIL oh DOE sin) - Multum

Description : RAPAFLO is the brand name for silodosin, a selective antagonist of alpha-1 adrenoreceptors...

  • Indications
  • RAPAFLO, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studi
  •   Read More
Rapaflo silodosin (Pronunciation: SIL oh DOE sin - FDA

Description : RAPAFLO is the brand name for silodosin, a selective antagonist of alpha-1 adrenoreceptors. Th...

  • Indications
  • RAPAFLO is the brand name for silodosin, a selective antagonist of alpha-1 adrenoreceptors. The chemical name of silodosin is 1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2trifl
  •   Read More
Rapaflo  silodosin (Pronunciation: SIL oh DOE sin) - Multum

Description : RAPAFLO is the brand name for silodosin, a selective antagonist of alpha-1 adrenoreceptors. Th...

  • Indications
  • RAPAFLO, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studi
  •   Read More
Rapamune sirolimus (Pronunciation: sih RO lim us) - FDA

Description : Rapamune (sirolimus) is an immunosuppressive agent. Sirolimus is a macrocyclic lactone prod...

  • Indications
  • Prophylaxis of Organ Rejection in Renal Transplantation Rapamune (sirolimus) is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiv
  •   Read More
Rapamune sirolimus (Pronunciation: sih RO lim us) - Multum

Description : Rapamune (sirolimus) is an immunosuppressive agent. Sirolimus is a macrocyclic lactone prod...

  • Indications
  • Prophylaxis of Organ Rejection in Renal Transplantation Rapamune (sirolimus) is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiv
  •   Read More
Rapamune sirolimus (Pronunciation: sih RO lim us) - FDA

Description : Rapamune (sirolimus) is an immunosuppressive agent. Sirolimus is a macrocyclic lactone produced...

  • Indications
  • Prophylaxis Of Organ Rejection In Renal Transplantation Rapamune (sirolimus) is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiv
  •   Read More
Rapamune sirolimus (Pronunciation: sih RO lim us) - Multum

Description : Rapamune (sirolimus) is an immunosuppressive agent. Sirolimus is a macrocyclic lactone produced...

  • Indications
  • Prophylaxis Of Organ Rejection In Renal Transplantation Rapamune (sirolimus) is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiv
  •   Read More
Rapivab peramivir) Injection - FDA

Description : RAPIVAB (peramivir) is an inhibitor of influenza virus neuraminidase. The chemical name is ...

  • Indications
  • RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than 2 days. Limitations of
  •   Read More
Rapivab (peramivir) Injection - FDA

Description : RAPIVAB (peramivir) is an inhibitor of influenza virus neuraminidase. The chemical name is ...

  • Indications
  • RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than 2 days. Limitations of
  •   Read More
Raplon (rapacuronium bromide) for Injection - FDA

Description : RAPLONTM (rapacuronium bromide) for Injection THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATE...

  • Indications
  • RAPLONTM (rapacuronium bromide) for injection is indicated as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation dur
  •   Read More
Raplon (rapacuronium bromide) for Injection - FDA

Description : RAPLONTM (rapacuronium bromide) for Injection THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATE...

  • Indications
  • RAPLONTM (rapacuronium bromide) for injection is indicated as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation
  •   Read More
Raptiva efalizumab (Pronunciation: EF a LIZ oo mab) - FDA

Description : RAPTIVA® (efalizumab) is an immunosuppressive recombinant humanized IgG1 kappa isotype ...

  • Indications
  • RAPTIVA® (efalizumab) is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic
  •   Read More
Raptiva efalizumab (Pronunciation: EF a LIZ oo mab) - Multum

Description : RAPTIVA® (efalizumab) is an immunosuppressive recombinant humanized IgG1 kappa isotype ...

  • Indications
  • RAPTIVA® (efalizumab) is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic
  •   Read More
Raptiva efalizumab (Pronunciation: EF a LIZ oo mab) - FDA

Description : RAPTIVA® (efalizumab) is an immunosuppressive recombinant humanized IgG1 kappa isotype ...

  • Indications
  • RAPTIVA® (efalizumab) is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for syst
  •   Read More
Raptiva efalizumab (Pronunciation: EF a LIZ oo mab) - Multum

Description : RAPTIVA® (efalizumab) is an immunosuppressive recombinant humanized IgG1 kappa isotype ...

  • Indications
  • RAPTIVA® (efalizumab) is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for syst
  •   Read More
Rasuvo (methotrexate) Non-pyrogenic Solution for a Single - FDA

Description : Rasuvo contains methotrexate, a folate analog metabolic inhibitor. Chemically, methotrex...

  • Indications
  • Rheumatoid Arthritis Including Polyarticular Juvenile Idiopathic Arthritis Rasuvo is indicated in the management of selected adults with severe, activerheumatoid arthritis&nb
  •   Read More
Rasuvo (methotrexate) Non-pyrogenic Solution for a Single - FDA

Description : Rasuvo contains methotrexate, a folate analog metabolic inhibitor. Chemically, methotrexat...

  • Indications
  • Rheumatoid Arthritis Including Polyarticular Juvenile Idiopathic Arthritis Rasuvo is indicated in the management of selected adults with severe, active rheumatoid arthrit
  •   Read More
Rattlesnake Antivenin  (antivenin crotalidae polyvalent) (Crotalidae Pol - FDA

Description : Composition Antivenin (Crotalidae) Polyvalent, Wyeth, is a refined and concentrated prepar...

  • Indications
  • Antivenin is indicated only for the treatment of envenomation caused by bites of those crotalids (pit vipers) specified in the immediately preceding paragraph. Pit Viper
  •   Read More
Rattlesnake Antivenin (Crotalidae Polyvalent [Equine]) - FDA

Description : Composition Antivenin (Crotalidae) Polyvalent, Wyeth, is a refined and concentrated prepar...

  • Indications
  • Antivenin is indicated only for the treatment of envenomation caused by bites of those crotalids (pit vipers) specified in the immediately preceding paragraph. Pit Viper
  •   Read More
Ravicti (glycerol phenylbutyrate) Oral Liquid - FDA

Description : RAVICTI (glycerol phenylbutyrate) is a clear, colorless to pale yellow oral liquid. It is i...

  • Indications
  • RAVICTI is indicated for use as a nitrogen-binding agent for chronic management of adult and pediatric patients ≥ 2 years of age with urea cycle disorders (UCDs) who ca
  •   Read More
Ravicti (glycerol phenylbutyrate) Oral Liquid - FDA

Description : RAVICTI (glycerol phenylbutyrate) is a clear, colorless to pale yellow oral liquid. It is i...

  • Indications
  • RAVICTI is indicated for use as a nitrogen-binding agent for chronic management of adult and pediatric patients ≥ 2 years of age with urea cycle disorders (UCDs) who ca
  •   Read More
Raxar grepafloxacin) - FDA

Description : RAXAR Tablets contain grepafloxacin hydrochloride RAXAR (grepafloxacin) is a broad-spectrum...

  • Indications
  • RAXAR (grepafloxacin) Tablets are indicated for treatment of adults with mild to moderate infections caused by susceptible strains of the designated microorganisms in the
  •   Read More
Raxar (grepafloxacin) - FDA

Description : RAXAR Tablets contain grepafloxacin hydrochloride RAXAR (grepafloxacin) is a broad-spectrum...

  • Indications
  • RAXAR (grepafloxacin) Tablets are indicated for treatment of adults with mild to moderate infections caused by susceptible strains of the designated microorganisms in the
  •   Read More
RAYOS  (prednisone) Delayed-release Tablets - FDA

Description : The active ingredient in RAYOS is prednisone (a corticosteroid). Corticosteroids are adren...

  • Indications
  • RAYOS is indicated in the treatment of the following diseases or conditions: Allergic Conditions Control of severe or incapacitating allergic conditions intractable to a
  •   Read More
Rayos prednisone) Delayed-release Tablets - FDA

Description : The active ingredient in RAYOS is prednisone (a corticosteroid). Corticosteroids are adren...

  • Indications
  • RAYOS is indicated in the treatment of the following diseases or conditions: Allergic Conditions Control of severe or incapacitating allergic conditions intractable to a
  •   Read More
Razadyne, Razadyne ER galantamine (Pronunciation: ga LAN ta meen) - FDA

Description : RAZADYNE® ER and RAZADYNE® (galantamine hydrobromide) is galantamine hydrobromide, ...

  • Indications
  • RAZADYNE® ER and RAZADYNE® (galantamine hydrobromide) are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
  •   Read More
Razadyne, Razadyne ER galantamine (Pronunciation: ga LAN ta meen) - Multum

Description : RAZADYNE® ER and RAZADYNE® (galantamine hydrobromide) is galantamine hydrobromide, ...

  • Indications
  • RAZADYNE® ER and RAZADYNE® (galantamine hydrobromide) are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
  •   Read More
Razadyne, Razadyne ER galantamine (Pronunciation: ga LAN ta meen) - FDA

Description : RAZADYNE® ER capsules, RAZADYNE® tablets, and RAZADYNE® oral solution contain g...

  • Indications
  • RAZADYNE® ER and RAZADYNE® are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
  •   Read More
Razadyne, Razadyne ER galantamine (Pronunciation: ga LAN ta meen) - Multum

Description : RAZADYNE® ER capsules, RAZADYNE® tablets, and RAZADYNE® oral solution contain g...

  • Indications
  • RAZADYNE® ER and RAZADYNE® are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
  •   Read More
Rebetron interferon alfa-2b and ribavirin (Pronunciation: i - FDA

Description : REBETOL® REBETOL is Schering Corporation's brand name for ribavirin, a nucleoside anal...

  • Indications
  • REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patient
  •   Read More
Rebetron interferon alfa-2b and ribavirin (Pronunciation: i - Multum

Description : REBETOL® REBETOL is Schering Corporation's brand name for ribavirin, a nucleoside anal...

  • Indications
  • REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patient
  •   Read More
Rebetron interferon alfa-2b and ribavirin (Pronunciation: i - FDA

Description : REBETOL® REBETOL is Schering Corporation's brand name for ribavirin, a nucleoside anal...

  • Indications
  • REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patient
  •   Read More
Rebetron interferon alfa-2b and ribavirin (Pronunciation: i - Multum

Description : REBETOL® REBETOL is Schering Corporation's brand name for ribavirin, a nucleoside anal...

  • Indications
  • REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patient
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - FDA

Description : Reclast contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclasti...

  • Indications
  • Treatment Of Osteoporosis In Postmenopausal Women Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis,
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - Multum

Description : Reclast contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclasti...

  • Indications
  • Treatment Of Osteoporosis In Postmenopausal Women Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis,
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - FDA

Description : Zometa contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bon...

  • Indications
  • Hypercalcemia Of Malignancy Zometa is indicated for the treatment of hypercalcemia of malignancy defined as an albumin-corrected calcium (cCa) of greater than or equal to
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - Multum

Description : Zometa contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bon...

  • Indications
  • Hypercalcemia Of Malignancy Zometa is indicated for the treatment of hypercalcemia of malignancy defined as an albumin-corrected calcium (cCa) of greater than or equal to
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - FDA

Description : Reclast contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bo...

  • Indications
  • Treatment Of Osteoporosis In Postmenopausal Women Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis,
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - Multum

Description : Reclast contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bo...

  • Indications
  • Treatment Of Osteoporosis In Postmenopausal Women Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis,
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - FDA

Description : Zometa contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bon...

  • Indications
  • Hypercalcemia Of Malignancy Zometa is indicated for the treatment of hypercalcemia of malignancy defined as an albumin-corrected calcium (cCa) of greater than or equal to
  •   Read More
Reclast, Zometa zoledronic acid (Pronunciation: zole DRO nik AS si - Multum

Description : Zometa contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bon...

  • Indications
  • Hypercalcemia Of Malignancy Zometa is indicated for the treatment of hypercalcemia of malignancy defined as an albumin-corrected calcium (cCa) of greater than or equal to
  •   Read More
Recombivax (Recombinant) - FDA

Description : RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) is a sterile suspension of non-infectious s...

  • Indications
  • RECOMBIVAX HB® [Hepatitis B Vaccine, Recombinant] is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved f
  •   Read More
Recombivax Hepatitis B Vaccine (Recombinant) - FDA

Description : RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) is a sterile suspension of non-infectious s...

  • Indications
  • RECOMBIVAX HB® [Hepatitis B Vaccine, Recombinant] is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approv
  •   Read More
Rectiv nitroglycerin (rectal) (Pronunciation: NYE troe GL - FDA

Description : Nitroglycerin is 1,2,3,-propanetriol trinitrate, an organic nitrate whose structural formul...

  • Indications
  • RECTIV™ (nitroglycerin) Ointment 0.4% is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.
  •   Read More
Rectiv nitroglycerin (rectal) (Pronunciation: NYE troe GL - Multum

Description : Nitroglycerin is 1,2,3,-propanetriol trinitrate, an organic nitrate whose structural formul...

  • Indications
  • RECTIV™ (nitroglycerin) Ointment 0.4% is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.
  •   Read More
Rectiv nitroglycerin (rectal) (Pronunciation: NYE troe GL - FDA

Description : Nitroglycerin is 1,2,3,-propanetriol trinitrate, an organic nitrate whose structural formul...

  • Indications
  • RECTIV™ (nitroglycerin) Ointment 0.4% is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.
  •   Read More
Rectiv nitroglycerin (rectal) (Pronunciation: NYE troe GL - Multum

Description : Nitroglycerin is 1,2,3,-propanetriol trinitrate, an organic nitrate whose structural formul...

  • Indications
  • RECTIV™ (nitroglycerin) Ointment 0.4% is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.
  •   Read More
Redux dexfenfluramine hydrochloride capsules - FDA

Description : Redux (dexfenfluramine hydrochloride capsules), an anti-obesity drug, is a serotonin reupta...

  • Indications
  • Dexfenfluramine is indicated for the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet. Dexfenfluramine hydr
  •   Read More
Redux (dexfenfluramine hydrochloride capsules) - FDA

Description : Redux (dexfenfluramine hydrochloride capsules), an anti-obesity drug, is a serotonin reupta...

  • Indications
  • Dexfenfluramine is indicated for the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet. Dexfenfluramine hydr
  •   Read More
Refludan lepirudin (Pronunciation: LEP i roo din) - FDA

Description : REFLUDAN [lepirudin (rDNA) for injection] is a highly specific direct inhibitor of thrombin...

  • Indications
  • REFLUDAN (lepirudin) is indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent fur
  •   Read More
Refludan lepirudin (Pronunciation: LEP i roo din) - Multum

Description : REFLUDAN [lepirudin (rDNA) for injection] is a highly specific direct inhibitor of thrombin...

  • Indications
  • REFLUDAN (lepirudin) is indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent further
  •   Read More
Refludan lepirudin (Pronunciation: LEP i roo din) - FDA

Description : REFLUDAN [lepirudin (rDNA) for injection] is a highly specific direct inhibitor of thrombin...

  • Indications
  • REFLUDAN (lepirudin) is indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent fur
  •   Read More
Refludan lepirudin (Pronunciation: LEP i roo din) - Multum

Description : REFLUDAN [lepirudin (rDNA) for injection] is a highly specific direct inhibitor of thrombin...

  • Indications
  • REFLUDAN (lepirudin) is indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent fur
  •   Read More
Reglan Injection (metoclopramide) Injection, USP - FDA

Description : Metoclopramide hydrochloride is a white crystalline, odorless substance, freely soluble in wate...

  • Indications
  • Diabetic Gastroparesis (Diabetic Gastric Stasis) REGLAN (metoclopramide hydrochloride, USP) is indicated for the relief of symptoms associated with acute and recurrent diabet
  •   Read More
Reglan Injection (metoclopramide) Injection, USP - FDA

Description : Metoclopramide hydrochloride is a white crystalline, odorless substance, freely soluble in ...

  • Indications
  • Diabetic Gastroparesis (Diabetic Gastric Stasis) REGLAN (metoclopramide hydrochloride, USP) is indicated for the relief of symptoms associated with acute and recurrent di
  •   Read More
Reglan ODT,Metozolv ODT, Reglan metoclopramide (Pronunciation: MET oh KLOE pra mid - FDA

Description : REGLAN ODT™ (metoclopramide orally disintegrating tablets) is an orally administere...

  • Indications
  • The use of REGLAN ODT™ (metoclopramide orally disintegrating tablets) is recommended for adults only. Therapy should not exceed 12 weeks in duration. Symptomatic Gastro
  •   Read More
Reglan ODT,Metozolv ODT, Reglan metoclopramide (Pronunciation: MET oh KLOE pra mid - Multum

Description : REGLAN ODT™ (metoclopramide orally disintegrating tablets) is an orally administered form...

  • Indications
  • The use of REGLAN ODT™ (metoclopramide orally disintegrating tablets) is recommended for adults only. Therapy should not exceed 12 weeks in duration. Symptomatic
  •   Read More
Regranex becaplermin topical (Pronunciation: be KAP ler min - FDA

Description : REGRANEX Gel contains becaplermin, a recombinant human platelet-derived growth factor for t...

  • Indications
  • Indication REGRANEX (becaplermin) Gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and
  •   Read More
Regranex becaplermin topical (Pronunciation: be KAP ler min - Multum

Description : REGRANEX Gel contains becaplermin, a recombinant human platelet-derived growth factor for t...

  • Indications
  • Indication REGRANEX (becaplermin) Gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and
  •   Read More
Regranex becaplermin topical (Pronunciation: be KAP ler min - FDA

Description : REGRANEX Gel contains becaplermin, a recombinant human platelet-derived growth factor for t...

  • Indications
  • Indication REGRANEX (becaplermin) Gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and
  •   Read More
Regranex becaplermin topical (Pronunciation: be KAP ler min - Multum

Description : REGRANEX Gel contains becaplermin, a recombinant human platelet-derived growth factor for t...

  • Indications
  • Indication REGRANEX (becaplermin) Gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and
  •   Read More
Relafen nabumetone (Pronunciation: na BUE me tone) - FDA

Description : RELAFEN (nabumetone) is a naphthylalkanone designated chemically as 4-(6-methoxy-2-naphthalenyl...

  • Indications
  • Carefully consider the potential benefits and risks of RELAFEN (nabumetone) and other treatment options before deciding to use RELAFEN (nabumetone) . Use the lowest effect
  •   Read More
Relafen nabumetone (Pronunciation: na BUE me tone) - Multum

Description : RELAFEN (nabumetone) is a naphthylalkanone designated chemically as 4-(6-methoxy-2-naphthalenyl...

  • Indications
  • Carefully consider the potential benefits and risks of RELAFEN (nabumetone) and other treatment options before deciding to use RELAFEN (nabumetone) . Use the lowest effect
  •   Read More
Relafen nabumetone (Pronunciation: na BUE me tone) - FDA

Description : RELAFEN (nabumetone) is a naphthylalkanone designated chemically as 4-(6-methoxy-2-naphthalenyl...

  • Indications
  • Carefully consider the potential benefits and risks of RELAFEN (nabumetone) and other treatment options before deciding to use RELAFEN (nabumetone) . Use the lowest effect
  •   Read More
Relafen nabumetone (Pronunciation: na BUE me tone) - Multum

Description : RELAFEN (nabumetone) is a naphthylalkanone designated chemically as 4-(6-methoxy-2-naphthalenyl...

  • Indications
  • Carefully consider the potential benefits and risks of RELAFEN (nabumetone) and other treatment options before deciding to use RELAFEN (nabumetone) . Use the lowest effect
  •   Read More
Relenza zanamivir (Pronunciation: zan AM i vir) - FDA

Description : The active component of RELENZA is zanamivir. The chemical name of zanamivir is 5- (acetyla...

  • Indications
  • Treatment of Influenza RELENZA® (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated acute illness due to influenza A and B virus in adults and p
  •   Read More
Relenza zanamivir (Pronunciation: zan AM i vir) - Multum

Description : The active component of RELENZA is zanamivir. The chemical name of zanamivir is 5- (acetyla...

  • Indications
  • Treatment of Influenza RELENZA® (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated acute illness due to influenza A and B virus in adults and p
  •   Read More
Relenza zanamivir (Pronunciation: zan AM i vir) - FDA

Description : The active component of RELENZA is zanamivir. The chemical name of zanamivir is 5- (acetylamino...

  • Indications
  • Treatment of Influenza RELENZA® (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated acute illness due to influenza A and B
  •   Read More
Relenza zanamivir (Pronunciation: zan AM i vir) - Multum

Description : The active component of RELENZA is zanamivir. The chemical name of zanamivir is 5- (acetylamino...

  • Indications
  • Treatment of Influenza RELENZA® (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated acute illness due to influenza A and B
  •   Read More
Relistor methylnaltrexone (Pronunciation: METh IL nal TREX - FDA

Description : RELISTOR (methylnaltrexone bromide) injection, a mu-opioid receptorantagonist, is a steril...

  • Indications
  • Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain RELISTOR is indicated for the treatment of opioid-induced constipation in adult patients with
  •   Read More
Relistor methylnaltrexone (Pronunciation: METh IL nal TREX - Multum

Description : RELISTOR (methylnaltrexone bromide) injection, a mu-opioid receptorantagonist, is a steril...

  • Indications
  • Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain RELISTOR is indicated for the treatment of opioid-induced constipation in adult patients with
  •   Read More
Relistor methylnaltrexone (Pronunciation: METh IL nal TREX - FDA

Description : RELISTOR (methylnaltrexone bromide) injection, a mu-opioid receptor antagonist, is a steril...

  • Indications
  • Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain RELISTOR is indicated for the treatment of opioid-induced constipation in adult patients with c
  •   Read More
Relistor methylnaltrexone (Pronunciation: METh IL nal TREX - Multum

Description : RELISTOR (methylnaltrexone bromide) injection, a mu-opioid receptor antagonist, is a steril...

  • Indications
  • Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain RELISTOR is indicated for the treatment of opioid-induced constipation in adult patients with c
  •   Read More
Relpax eletriptan (Pronunciation: EL e TRIP tan) - FDA

Description : RELPAX (eletriptan hydrobromide) tablets contain eletriptan hydrobromide, which is a select...

  • Indications
  • RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been establish
  •   Read More
Relpax eletriptan (Pronunciation: EL e TRIP tan) - Multum

Description : RELPAX (eletriptan hydrobromide) tablets contain eletriptan hydrobromide, which is a select...

  • Indications
  • RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been establish
  •   Read More
Relpax eletriptan (Pronunciation: EL e TRIP tan) - FDA

Description : RELPAX (eletriptan hydrobromide) tablets contain eletriptan hydrobromide, which is a select...

  • Indications
  • RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been establish
  •   Read More
Relpax eletriptan (Pronunciation: EL e TRIP tan) - Multum

Description : RELPAX (eletriptan hydrobromide) tablets contain eletriptan hydrobromide, which is a select...

  • Indications
  • RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been establish
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - FDA

Description : REMERON® (mirtazapine) Tablets are an orally administered drug. Mirtazapine has a tet...

  • Indications
  • REMERON® (mirtazapine) Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON in the treatment of major depressive disorder w
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - Multum

Description : REMERON® (mirtazapine) Tablets are an orally administered drug. Mirtazapine has a tetra-cyc...

  • Indications
  • REMERON® (mirtazapine) Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON in the treatment of major depressive disorder was est
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - FDA

Description : REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are an orally administered drug....

  • Indications
  • REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON® (mirtazapine) Tablet
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - Multum

Description : REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are an orally administered drug....

  • Indications
  • REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON® (mirtazapine) Tablet
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - FDA

Description : REMERON® (mirtazapine) Tablets are an orally administered drug. Mirtazapine has a tetra...

  • Indications
  • REMERON® (mirtazapine) Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON in the treatment of major depressive disorder was
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - Multum

Description : REMERON® (mirtazapine) Tablets are an orally administered drug. Mirtazapine has a tetra...

  • Indications
  • REMERON® (mirtazapine) Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON in the treatment of major depressive disorder was
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - FDA

Description : REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are an orally administered d...

  • Indications
  • REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON® (mirtazapine) Ta
  •   Read More
Remeron, Remeron SolTab mirtazapine (Pronunciation: mir TAZ a peen) - Multum

Description : REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are an orally administered d...

  • Indications
  • REMERONSolTab® (mirtazapine) Orally Disintegrating Tablets are indicated for the treatment of major depressive disorder. The efficacy of REMERON® (mirtazapine)
  •   Read More
Remicade infliximab (Pronunciation: in FLIX ih mab) - FDA

Description : Infliximab, the active ingredient in REMICADE, is a chimeric IgG1κ monoclonal antibod...

  • Indications
  • Crohn's Disease REMICADE is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active
  •   Read More
Remicade infliximab (Pronunciation: in FLIX ih mab) - Multum

Description : Infliximab, the active ingredient in REMICADE, is a chimeric IgG1κ monoclonal antibod...

  • Indications
  • Crohn's Disease REMICADE is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active
  •   Read More
Remicade infliximab (Pronunciation: in FLIX ih mab) - FDA

Description : Infliximab, the active ingredient in REMICADE, is a chimeric IgG1κ monoclonal antibod...

  • Indications
  • Crohn's Disease REMICADE is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active
  •   Read More
Remicade infliximab (Pronunciation: in FLIX ih mab) - Multum

Description : Infliximab, the active ingredient in REMICADE, is a chimeric IgG1κ monoclonal antibod...

  • Indications
  • Crohn's Disease REMICADE is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active
  •   Read More
Remodulin treprostinil injection (Pronunciation: tre PROS ti - FDA

Description : Remodulin (treprostinil) Injection is a sterile solution of treprostinil formulated for sub...

  • Indications
  • Pulmonary Arterial Hypertension Remodulin is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to diminish symptoms associated with exerc
  •   Read More
Remodulin treprostinil injection (Pronunciation: tre PROS ti - Multum

Description : Remodulin (treprostinil) Injection is a sterile solution of treprostinil formulated for sub...

  • Indications
  • Pulmonary Arterial Hypertension Remodulin is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to diminish symptoms associated with exerc
  •   Read More
Renacidin (Citric Acid, Glucono-delta-lactone and Magnesium - FDA

Description : Renacidin® (citric acid, glucono-delta-lactone and magnesium carbonate irrigation) (Cit...

  • Indications
  • Renacidin (citric acid, glucono-delta-lactone and magnesium carbonate irrigation) Irrigation is indicated for use by local irrigation in the dissolution of renal calculi c
  •   Read More
Renacidin (Citric Acid, Glucono-delta-lactone and Magnesium - FDA

Description : Renacidin® (citric acid, glucono-delta-lactone and magnesium carbonate irrigation) (Cit...

  • Indications
  • Renacidin (citric acid, glucono-delta-lactone and magnesium carbonate irrigation) Irrigation is indicated for use by local irrigation in the dissolution of renal calculi c
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - FDA

Description : The active ingredient in Renagel Tablets is sevelamer hydrochloride, a polymeric amine that...

  • Indications
  • RENAGEL® (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and efficacy
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - Multum

Description : The active ingredient in Renagel Tablets is sevelamer hydrochloride, a polymeric amine that...

  • Indications
  • RENAGEL® (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and efficacy
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - FDA

Description : The active ingredient in Renvela is sevelamer carbonate, a polymeric amine that binds phosp...

  • Indications
  • Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - Multum

Description : The active ingredient in Renvela is sevelamer carbonate, a polymeric amine that binds phosp...

  • Indications
  • Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - FDA

Description : The active ingredient in Renvela is sevelamer carbonate, a polymeric amine that binds phosphate...

  • Indications
  • Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - Multum

Description : The active ingredient in Renvela is sevelamer carbonate, a polymeric amine that binds phosphate...

  • Indications
  • Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - FDA

Description : The active ingredient in Renagel Tablets is sevelamer hydrochloride, a polymeri...

  • Indications
  • RENAGEL® (sevelamer hydrochloride) is indicated for the control of serumphosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and effi
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - FDA

Description : The active ingredient in Renagel Tablets is sevelamer hydrochloride, a polymeric ...

  • Indications
  • RENAGEL® (sevelamer hydrochloride) is indicated for the control of serumphosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and effi
  •   Read More
Renagel, Renvela sevelamer (Pronunciation: se VEL a mer) - Multum

Description : The active ingredient in Renagel Tablets is sevelamer hydrochloride, a polymeric ...

  • Indications
  • RENAGEL® (sevelamer hydrochloride) is indicated for the control of serumphosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and effi
  •   Read More
Renese polythiazide) Tablets for Oral Administration - FDA

Description : Renese® is designated generically as polythiazide, and chemically as 2H-1,2,4-Benzothia...

  • Indications
  • Renese (polythiazide) is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Re
  •   Read More
Renese (polythiazide) Tablets for Oral Administration - FDA

Description : Renese® is designated generically as polythiazide, and chemically as 2H-1,2,4-Benzothia...

  • Indications
  • Renese (polythiazide) is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Re
  •   Read More
ReoPro (abciximab) for Intravenous Administration - FDA

Description : Abciximab, ReoPro®, is the Fab fragment of the chimeric human-murine monoclonal antibody 7E...

  • Indications
  • Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous cor
  •   Read More
ReoPro (abciximab) for Intravenous Administration - FDA

Description : Abciximab, ReoPro®, is the Fab fragment of the chimeric human-murine monoclonal antibod...

  • Indications
  • Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous cor
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - FDA

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is the hydr...

  • Indications
  • Parkinson's Disease REQUIP (ropinirole hcl) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The effectiveness of REQUIP (ropi
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - Multum

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is the hydr...

  • Indications
  • Parkinson's Disease REQUIP (ropinirole hcl) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The effectiveness of REQUIP (ropi
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - FDA

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is supplied...

  • Indications
  • Parkinson's DiseaseREQUIP XL (ropinirole extended-release tablets) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease.
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - Multum

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is supplied...

  • Indications
  • Parkinson's Disease REQUIP XL (ropinirole extended-release tablets) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease.
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - FDA

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is supplied...

  • Indications
  • Parkinson's Disease REQUIP XL (ropinirole extended-release tablets) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease.
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - Multum

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is supplied...

  • Indications
  • Parkinson's Disease REQUIP XL (ropinirole extended-release tablets) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease.
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - FDA

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is the hydr...

  • Indications
  • Parkinson's Disease REQUIP (ropinirole hcl) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The effectiveness of REQUIP (ropi
  •   Read More
Requip, Requip XL ropinirole (oral) (Pronunciation: roe PIN i role) - Multum

Description : REQUIP (ropinirole) is an orally administered non-ergoline dopamine agonist. It is the hydr...

  • Indications
  • Parkinson's Disease REQUIP (ropinirole hcl) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The effectiveness of REQUIP (ropi
  •   Read More
Rescriptor delavirdine (Pronunciation: de la VIR deen) - FDA

Description : RESCRIPTOR Tablets contain delavirdine mesylate, a synthetic non-nucleoside reverse transcr...

  • Indications
  • RESCRIPTOR Tablets are indicated for the treatment of HIV-1 infection in combination with at least 2 other active antiretroviral agents when therapy is warranted. The fol
  •   Read More
Rescriptor  delavirdine (Pronunciation: de la VIR deen) - Multum

Description : RESCRIPTOR Tablets contain delavirdine mesylate, a synthetic non-nucleoside reverse transcr...

  • Indications
  • RESCRIPTOR Tablets are indicated for the treatment of HIV-1 infection in combination with at least 2 other active antiretroviral agents when therapy is warranted. The fol
  •   Read More
Rescriptor delavirdine (Pronunciation: de la VIR deen) - FDA

Description : RESCRIPTOR Tablets contain delavirdine mesylate, a synthetic non-nucleoside reverse transcr...

  • Indications
  • RESCRIPTOR Tablets are indicated for the treatment of HIV-1 infection in combination with at least 2 other active antiretroviral agents when therapy is warranted. The fol
  •   Read More
Rescriptor delavirdine (Pronunciation: de la VIR deen) - Multum

Description : RESCRIPTOR Tablets contain delavirdine mesylate, a synthetic non-nucleoside reverse transcr...

  • Indications
  • RESCRIPTOR Tablets are indicated for the treatment of HIV-1 infection in combination with at least 2 other active antiretroviral agents when therapy is warranted. The fol
  •   Read More
Rescula (unoprostone isopropyl) Ophthalmic Solution - FDA

Description : Rescula (unoprostone isopropyl) Ophthalmic Solution 0.15% is a synthetic docosanoid. Unopro...

  • Indications
  • Rescula (unoprostone isopropyl) Ophthalmic Solution 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
  •   Read More
Rescula (unoprostone isopropyl) Ophthalmic Solution - FDA

Description : Rescula (unoprostone isopropyl) Ophthalmic Solution 0.15% is a synthetic docosanoid. Unopro...

  • Indications
  • Rescula (unoprostone isopropyl) Ophthalmic Solution 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  •   Read More
Restasis cyclosporine ophthalmic (Pronunciation: SYE kloe S - FDA

Description : RESTASIS® (cyclosporine) ophthalmic emulsion 0.05% contains a topical immunomodulator w...

  • Indications
  • RESTASIS® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associ
  •   Read More
Restasis cyclosporine ophthalmic (Pronunciation: SYE kloe S - Multum

Description : RESTASIS® (cyclosporine) ophthalmic emulsion 0.05% contains a topical immunomodulator w...

  • Indications
  • RESTASIS® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associ
  •   Read More
Restasis cyclosporine ophthalmic (Pronunciation: SYE kloe S - FDA

Description : RESTASIS® (cyclosporine) ophthalmic emulsion 0.05% contains a topical immunomodulator w...

  • Indications
  • RESTASIS® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associ
  •   Read More
Restasis cyclosporine ophthalmic (Pronunciation: SYE kloe S - Multum

Description : RESTASIS® (cyclosporine) ophthalmic emulsion 0.05% contains a topical immunomodulator w...

  • Indications
  • RESTASIS® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associ
  •   Read More
Restoril temazepam (Pronunciation: te MAZ e pam) - FDA

Description : Restoril™ (temazepam) is a benzodiazepine hypnotic agent. The chemical name is 7-chlo...

  • Indications
  • Restoril™ (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the pre
  •   Read More
Restoril temazepam (Pronunciation: te MAZ e pam) - Multum

Description : Restoril™ (temazepam) is a benzodiazepine hypnotic agent. The chemical name is 7-chlo...

  • Indications
  • Restoril™ (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the pre
  •   Read More
Restylane hyaluronic acid) Dermal Filler Injectable Gel - FDA

Description : Restylane is a gel of hyaluronic acid generated by Streptococcus species of...

  • Indications
  • Restylane is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane i
  •   Read More
Restylane (hyaluronic acid) Dermal Filler Injectable Gel - FDA

Description : Restylane is a gel of hyaluronic acid generated by Streptococcus species of bacteria, chem...

  • Indications
  • Restylane is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane is indi
  •   Read More
Restylane-L (hyaluronic acid) Dermal Filler Injectable Gel wit - FDA

Description : Restylane-L is a gel of hyaluronic acid generated by Streptococcus species ...

  • Indications
  • Restylane-L is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane-L is indi
  •   Read More
Restylane-L (hyaluronic acid) Dermal Filler Injectable Gel wit - FDA

Description : Restylane-L is a gel of hyaluronic acid generated by Streptococcus sp...

  • Indications
  • Restylane-L is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane-L is indi
  •   Read More
Restylane-L (hyaluronic acid) Dermal Filler Injectable Gel wit - FDA

Description : Restylane-L is a gel of hyaluronic acid generated by Streptococcus species ...

  • Indications
  • Restylane-L is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane-L is indi
  •   Read More
Restylane-L (hyaluronic acid) Dermal Filler Injectable Gel wit - FDA

Description : Restylane-L is a gel of hyaluronic acid generated by Streptococcus species of bacteria, che...

  • Indications
  • Restylane-L is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane-L is
  •   Read More
Retavase retaplase (Pronunciation: RE te plase) - FDA

Description : Retavase® (Reteplase) is a non-glycosylated deletion mutein of tissue plasminogen activ...

  • Indications
  • Retavase® (Reteplase) is indicated for use in the management of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI,
  •   Read More
Retavase retaplase (Pronunciation: RE te plase) - Multum

Description : Retavase® (Reteplase) is a non-glycosylated deletion mutein of tissue plasminogen activ...

  • Indications
  • Retavase® (Reteplase) is indicated for use in the management of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI,
  •   Read More
Retavase retaplase (Pronunciation: RE te plase) - FDA

Description : Retavase® (Reteplase) is a non-glycosylated deletion mutein of tissue plasminogen activ...

  • Indications
  • Retavase® (Reteplase) is indicated for use in the management of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI,
  •   Read More
Retavase retaplase (Pronunciation: RE te plase) - Multum

Description : Retavase® (Reteplase) is a non-glycosylated deletion mutein of tissue plasminogen activ...

  • Indications
  • Retavase® (Reteplase) is indicated for use in the management of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI,
  •   Read More
Retisert fluocinolone ophthalmic implant (Pronunciation: fl - FDA

Description : RETISERT® (fluocinolone acetonide intravitreal implant) 0.59 mg is a sterile implant de...

  • Indications
  • RETISERT is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.
  •   Read More
Retisert fluocinolone ophthalmic implant (Pronunciation: fl - Multum

Description : RETISERT® (fluocinolone acetonide intravitreal implant) 0.59 mg is a sterile implant de...

  • Indications
  • RETISERT is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.
  •   Read More
Retisert fluocinolone ophthalmic implant (Pronunciation: fl - FDA

Description : RETISERT® (fluocinolone acetonide intravitreal implant) 0.59 mg is a sterile implant de...

  • Indications
  • RETISERT is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.
  •   Read More
Retisert fluocinolone ophthalmic implant (Pronunciation: fl - Multum

Description : RETISERT® (fluocinolone acetonide intravitreal implant) 0.59 mg is a sterile implant de...

  • Indications
  • RETISERT is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.
  •   Read More
Retrovir zidovudine (oral) (Pronunciation: zye DOE vyoo dee - FDA

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimid...

  • Indications
  • Treatment Of HIV-1 RETROVIR, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infect
  •   Read More
Retrovir zidovudine (oral) (Pronunciation: zye DOE vyoo dee - Multum

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimid...

  • Indications
  • Treatment Of HIV-1 RETROVIR, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infect
  •   Read More
Retrovir zidovudine (injection) (Pronunciation: zye DOE vyo - FDA

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimid...

  • Indications
  • RETROVIR IV (zidovudine injection) Infusion in combination with other antiretroviral agents is indicated for the treatment of HIV infection. Maternal-Fetal HIV Transmissi
  •   Read More
Retrovir zidovudine (injection) (Pronunciation: zye DOE vyo - Multum

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimid...

  • Indications
  • RETROVIR IV (zidovudine injection) Infusion in combination with other antiretroviral agents is indicated for the treatment of HIV infection. Maternal-Fetal HIV Transmissi
  •   Read More
Retrovir zidovudine (oral) (Pronunciation: zye DOE vyoo dee - FDA

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimidine ...

  • Indications
  • Treatment Of HIV-1 RETROVIR, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infect
  •   Read More
Retrovir zidovudine (oral) (Pronunciation: zye DOE vyoo dee - Multum

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimidine ...

  • Indications
  • Treatment Of HIV-1 RETROVIR, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infect
  •   Read More
Retrovir zidovudine (injection) (Pronunciation: zye DOE vyo - FDA

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimidine ...

  • Indications
  • RETROVIR IV (zidovudine injection) Infusion in combination with other antiretroviral agents is indicated for the treatment of HIV infection. Maternal-Fetal HIV Transmissi
  •   Read More
Retrovir zidovudine (injection) (Pronunciation: zye DOE vyo - Multum

Description : RETROVIR is the brand name for zidovudine (formerly called azidothymidine [AZT]), a pyrimidine ...

  • Indications
  • RETROVIR IV (zidovudine injection) Infusion in combination with other antiretroviral agents is indicated for the treatment of HIV infection. Maternal-Fetal HIV Transmissi
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - FDA

Description : REVATIO, phosphodiesterase-5 (PDE-5) inhibitor, is the citrate salt of sildenafil, a select...

  • Indications
  • REVATIO is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in adults to improve exercise ability and delay clinical worsening. The delay in cl
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - Multum

Description : REVATIO, phosphodiesterase-5 (PDE-5) inhibitor, is the citrate salt of sildenafil, a select...

  • Indications
  • REVATIO is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in adults to improve exercise ability and delay clinical worsening. The delay in cl
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - FDA

Description : REVATIO, phosphodiesterase-5 (PDE-5) inhibitor, is the citrate salt of sildenafil, a selective ...

  • Indications
  • REVATIO is indicated for the treatment of pulmonary arterial hypertension(WHO Group I) in adults to improve exercise ability and delay clinical worsening. The delay in cl
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - Multum

Description : REVATIO, phosphodiesterase-5 (PDE-5) inhibitor, is the citrate salt of sildenafil, a selective ...

  • Indications
  • REVATIO is indicated for the treatment of pulmonary arterial hypertension(WHO Group I) in adults to improve exercise ability and delay clinical worsening. The delay in cl
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - FDA

Description : VIAGRA (sildenafil citrate), an oral therapy for erectile dysfunction, is the citrate sal...

  • Indications
  • VIAGRA is indicated for the treatment of erectile dysfunction.
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - FDA

Description : VIAGRA (sildenafil citrate), an oral therapy for erectile dysfunction, is the citrate salt of s...

  • Indications
  • VIAGRA is indicated for the treatment of erectile dysfunction.
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - Multum

Description : VIAGRA (sildenafil citrate), an oral therapy for erectile dysfunction, is the citrate salt of s...

  • Indications
  • VIAGRA is indicated for the treatment of erectile dysfunction.
  •   Read More
Revatio, Viagra sildenafil (oral) (Pronunciation: sil DEN a fil) - Multum

Description : VIAGRA (sildenafil citrate), an oral therapy for erectile dysfunction, is the citrate salt of s...

  • Indications
  • VIAGRA is indicated for the treatment of erectile dysfunction.
  •   Read More
Revex (nalmefene hydrochloride) Injection, Solution - FDA

Description : REVEX (nalmefene hydrochloride injection), an opioid antagonist, is a 6-methylene analogue ...

  • Indications
  • REVEX is indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids. REVEX is
  •   Read More
Revex (nalmefene hydrochloride) Injection, Solution - FDA

Description : REVEX (nalmefene hydrochloride injection), an opioid antagonist, is a 6-methylene analogue ...

  • Indications
  • REVEX is indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids. REVEX is
  •   Read More
ReVia naltrexone (oral) (Pronunciation: nal TREX own) - FDA

Description : REVIA® (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic con...

  • Indications
  • REVIA is indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. REVIA has not been shown to provide any
  •   Read More
ReVia naltrexone (oral) (Pronunciation: nal TREX own) - Multum

Description : REVIA® (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic con...

  • Indications
  • REVIA is indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. REVIA has not been shown to provide any
  •   Read More
ReVia naltrexone (oral) (Pronunciation: nal TREX own) - FDA

Description : REVIA® (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic con...

  • Indications
  • REVIA is indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. REVIA has not been shown to provide any
  •   Read More
ReVia naltrexone (oral) (Pronunciation: nal TREX own) - Multum

Description : REVIA® (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic con...

  • Indications
  • REVIA is indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. REVIA has not been shown to provide any
  •   Read More
Revlimid lenalidomide (Pronunciation: LEN a LID o mide) - FDA

Description : REVLIMID, a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and anti...

  • Indications
  • Multiple Myeloma REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM) who have received at least one prior the
  •   Read More
Revlimid lenalidomide (Pronunciation: LEN a LID o mide) - Multum

Description : REVLIMID, a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and anti...

  • Indications
  • Multiple Myeloma REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM) who have received at least one prior the
  •   Read More
Revlimid lenalidomide (Pronunciation: LEN a LID o mide) - FDA

Description : REVLIMID, a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and anti...

  • Indications
  • Multiple Myeloma REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM). Myelodysplastic Syndromes REVLIMID
  •   Read More
Revlimid lenalidomide (Pronunciation: LEN a LID o mide) - Multum

Description : REVLIMID, a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and anti...

  • Indications
  • Multiple Myeloma REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM). Myelodysplastic Syndromes REVLIMID
  •   Read More
Reyataz  atazanavir (Pronunciation: a ta ZAN a vir) - FDA

Description : The active ingredient in REYATAZ capsules and oral powder is atazanavir sulfate, which is a...

  • Indications
  • REYATAZ® (atazanavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at lea
  •   Read More
Reyataz atazanavir (Pronunciation: a ta ZAN a vir) - FDA

Description : The active ingredient in REYATAZ capsules and oral powder is atazanavir sulfate, which is a...

  • Indications
  • REYATAZ® (atazanavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at lea
  •   Read More
Reyataz atazanavir (Pronunciation: a ta ZAN a vir) - Multum

Description : The active ingredient in REYATAZ capsules and oral powder is atazanavir sulfate, which is a...

  • Indications
  • REYATAZ® (atazanavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at lea
  •   Read More
Rezira hydrocodone bitartrate and pseudoephedrine hydroch - FDA

Description : REZIRA Oral Solution contains hydrocodone bitartrate (a semisynthetic centrally-acting opio...

  • Indications
  • Common Cold REZIRA™ Oral Solution (hydrocodone bitartrate and pseudoephedrine hydrochloride) is indicated for: Relief of cough and nasal congestion associated with
  •   Read More
Rezira (hydrocodone bitartrate and pseudoephedrine hydroc - FDA

Description : REZIRA Oral Solution contains hydrocodone bitartrate (a semisynthetic centrally-acting opio...

  • Indications
  • Common Cold REZIRA™ Oral Solution (hydrocodone bitartrate and pseudoephedrine hydrochloride) is indicated for: Relief of cough and nasal congestion associated with
  •   Read More
Rezulin (troglitazone) - FDA

Description : Rezulin (troglitazone) is an oral antihyperglycemic agent which acts primarily by decreasin...

  • Indications
  • Rezulin (troglitazone (removed from the us market 3/21/00)) may be used concomitantly with a sulfonylurea or insulin to improve glycemic control. Rezulin (troglitazone (re
  •   Read More
Rheumatrex (methotrexate) Tablets, USP - FDA

Description : Methotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain neop...

  • Indications
  • Neoplastic Diseases Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used
  •   Read More
Rheumatrex Dose Pack, Trexall methotrexate (oral) (Pronunciation: meth oh TREX a - FDA

Description : Trexall™ (methotrexate tablets, USP) (formerly Amethopterin) is an antimetabol...

  • Indications
  • Neoplastic Diseases: Trexall™ (methotrexate tablets) are indicated in the treatment of gestationalchoriocarcinoma, chorioadenoma destruens and hydatidiform mo
  •   Read More
Rheumatrex Dose Pack, Trexall methotrexate (oral) (Pronunciation: meth oh TREX a - Multum

Description : Trexall™ (methotrexate tablets, USP) (formerly Amethopterin) is an antimetabolite us...

  • Indications
  • Neoplastic Diseases: Trexall™ (methotrexate tablets) are indicated in the treatment of gestationalchoriocarcinoma, chorioadenoma destruens and hydatidif
  •   Read More
Rheumatrex Dose Pack, Trexall methotrexate (oral) (Pronunciation: meth oh TREX a - Multum

Description : Methotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain neop...

  • Indications
  • Neoplastic Diseases Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used
  •   Read More
Rheumatrex Dose Pack, Trexall methotrexate (oral) (Pronunciation: meth oh TREX a - FDA

Description : Methotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain ...

  • Indications
  • Neoplastic Diseases Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in ma
  •   Read More
Rheumatrex Dose Pack, Trexall methotrexate (oral) (Pronunciation: meth oh TREX a - Multum

Description : Methotrexate (formerly Amethopterin) is an antimetabolite used in the treatment of certain ...

  • Indications
  • Neoplastic Diseases Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in ma
  •   Read More
Rhinocort Aqua budesonide nasal (Pronunciation: byoo DEH so nide) - FDA

Description : Budesonide, the active ingredient of RHINOCORT AQUA (budesonide) Nasal Spray, is an anti-inflam...

  • Indications
  • Treatment of Seasonal or Perennial Allergic Rhinitis RHINOCORT AQUA (budesonide) Nasal Spray is indicated for the treatment of nasal symptoms of seasonal or perennial allergi
  •   Read More
Rhinocort Aqua budesonide nasal (Pronunciation: byoo DEH so nide) - FDA

Description : Budesonide, the active ingredient of RHINOCORT AQUA (budesonide) Nasal Spray, is an anti-in...

  • Indications
  • Treatment of Seasonal or Perennial Allergic Rhinitis RHINOCORT AQUA (budesonide) Nasal Spray is indicated for the treatment of nasal symptoms of seasonal or perennial all
  •   Read More
Rhinocort Aqua budesonide nasal (Pronunciation: byoo DEH so nide) - Multum

Description : Budesonide, the active ingredient of RHINOCORT AQUA (budesonide) Nasal Spray, is an anti-in...

  • Indications
  • Treatment of Seasonal or Perennial Allergic Rhinitis RHINOCORT AQUA (budesonide) Nasal Spray is indicated for the treatment of nasal symptoms of seasonal or perennial all
  •   Read More
RiaSTAP fibrinogen (Pronunciation: fye BRIN oh gen) - FDA

Description : RiaSTAP (fibrinogen concentrate human for intravenous use) is a heat-treated, lyophilized &...

  • Indications
  • RiaSTAP™ (fibrinogen concentrate (human) for intravenous use) , Fibrinogen Concentrate (Human) is indicated for the treatment of acute bleeding episodes in patients
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI